Doctor-led medical care · Ubi, Singapore 6844 1528 WhatsApp

GLP-1 Explained

Ozempic in Singapore: What It Is Licensed For, and What It Is Not

Ozempic is licensed in Singapore for type 2 diabetes, not weight management. What the label actually covers, why the confusion exists, and what is licensed for weight.

10 September 2026 · Updated 22 October 2026 · 8 min · Medically reviewed by Dr Joseph Wang

Unbranded medicine pack and tablets beside a stethoscope

Ozempic is one of the most-searched medicine names in Singapore — usually by people who have read about weight loss, not diabetes. That gap between what the name is known for and what it is actually registered for is worth understanding, because it determines what a doctor can and cannot lawfully offer you.

What it is

Ozempic contains semaglutide, given as a once-weekly injection, and acts on the GLP-1 receptor — one of the gut hormones released after eating that influence fullness, stomach emptying, insulin release and glucagon production. The class has been in clinical use for type 2 diabetes for years, so the safety profile is well characterised.

Semaglutide appears in more than one product, at different doses and with different registered indications. That single fact explains most of the confusion this page exists to resolve.

What the Singapore label covers

According to the Singapore product information, this product is indicated for adults with insufficiently controlled type 2 diabetes mellitus, as an adjunct to diet and exercise — as monotherapy where metformin is inappropriate, or in addition to other glucose-lowering medicines. It also carries two risk-reduction indications, both in people who already have type 2 diabetes:

  1. Kidney protection — to reduce the risk of sustained decline in kidney function, end-stage kidney disease and cardiovascular death, in adults with type 2 diabetes and chronic kidney disease.
  2. Cardiovascular protection — to reduce the risk of major adverse cardiovascular events, in adults with type 2 diabetes and established cardiovascular disease.

Those are serious, well-evidenced indications. None of them is weight management.

The distinction that matters

  • Weight management is not a registered indication for this product in Singapore. Using it for weight loss would be off-label use.
  • Off-label prescribing is not the same as approved treatment, and a clinic that advertises it as a weight-loss product is advertising something the label does not support.
  • Other medicines in the same class are registered for weight management here, with defined BMI thresholds in their own product information. That is a different product, a different approval and a different conversation.

This is why you will not find this clinic presenting it as a weight-loss product — not caution for its own sake, but because the honest answer serves you more than a sale.

Why the class attracts so much attention

The GLP-1 class has produced some of the most substantial weight-management results recorded in trials, and that is a genuine advance. The local context is real too: MOH’s 2022 National Population Health Survey found 36.2% of Singaporeans aged 18–74 were overweight and 11.8% obese.

The confusion arises because coverage describes the class by brand name, while each product carries its own approval. If you want the science without the brand noise, the GLP-1 guide and the semaglutide evidence summary cover it properly.

Why every route runs through a doctor

It is prescription-only in Singapore, and for reasons that are practical rather than bureaucratic:

  • It was prescribed for a specific indication by a doctor who knows your history.
  • It has contraindications and interactions that need screening — including a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and caution with a history of pancreatitis or gallbladder disease.
  • It needs monitoring: dose build-up, tolerance, and follow-up bloods where relevant.
  • Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation — usually settling as the dose stabilises, which is why titration is gradual.

For diabetes, that oversight is routine. For anyone seeking it for weight, the medical answer is different: an assessment, then a treatment that is actually licensed for that purpose.

If you are looking for weight treatment

Start with the assessment, not the product name. A doctor reviews your history, measurements and health markers, says whether medical treatment is appropriate at all, and — if it is — which licensed options fit and what monitoring looks like.

That is how our doctor-led weight management programme works: assessment first, treatment only where appropriate, and no claims the evidence does not support. If a particular molecule is what you have been reading about, these pages explain what is actually licensed for weight management here: tirzepatide, semaglutide for weight management and liraglutide.

Details of what an assessment involves, and what treatment at each stage consists of, are set out on the consultation rates page linked from the main navigation. The starting point is always a conversation rather than a product choice, in clinic or by teleconsult.

To arrange one, book a consultation.


This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for medical concerns, diagnosis, or treatment. Accord Medical Clinic is an MOH-registered medical clinic in Singapore. Dr Joseph Wang (Family Physician) provides medical weight management consultations.

Medicine information referenced from the Singapore National Drug Formulary product information for Ozempic (semaglutide), registration numbers SIN16164P and SIN16165P, last updated 2026. Population figures: MOH National Population Health Survey 2022.

Frequently asked questions

Is Ozempic approved for weight management in Singapore?

No. It is registered with the Health Sciences Authority for type 2 diabetes. Weight management is not a registered indication for this product here, and using it for that purpose is off-label — which is not something a responsible clinic promotes.

What exactly is it licensed for?

Three things, all in type 2 diabetes: improving blood sugar control as an adjunct to diet and exercise; reducing the risk of sustained kidney function decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease; and reducing the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.

Then why do people associate it with weight?

Because international coverage describes the GLP-1 class using brand names. The molecules differ in dose and licensing between products: some are registered specifically for weight management in Singapore while this one is registered for diabetes. The names are confusing precisely because they are similar — the approvals are not.

Which medicines are licensed for weight management in Singapore?

Several prescription options are registered for that purpose, with defined BMI thresholds in their Singapore product information. Which one suits a particular person is a clinical decision taken after assessment, not a product choice made from a website.

Can it be obtained without seeing a doctor?

No. It is prescription-only in Singapore. Supplying it without a prescription is unlawful, the product cannot be verified, and nobody is screening contraindications or monitoring you.

I want treatment for my weight — where do I start?

With an assessment, not a product name. That covers your history, measurements and health markers, whether medical treatment is appropriate at all, and if so which licensed options fit.

WhatsApp
Call WhatsApp Book now